280 related articles for article (PubMed ID: 28890385)
1. Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Ledent C; Tilley SL; Nayeem MA
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():83-95. PubMed ID: 28890385
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
3. Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(1):e0169584. PubMed ID: 28056085
[TBL] [Abstract][Full Text] [Related]
4. Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA
Am J Physiol Regul Integr Comp Physiol; 2016 Oct; 311(4):R676-R688. PubMed ID: 27488890
[TBL] [Abstract][Full Text] [Related]
5. Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Nayeem MA
PLoS One; 2016; 11(9):e0162147. PubMed ID: 27583776
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
[TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
Nayeem MA; Geldenhuys WJ; Hanif A
Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A
Hanif A; Agba SO; Ledent C; Tilley SL; Morisseau C; Nayeem MA
Mol Cell Biochem; 2021 May; 476(5):1965-1978. PubMed ID: 33511551
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
[TBL] [Abstract][Full Text] [Related]
10. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
[TBL] [Abstract][Full Text] [Related]
13. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
14. High salt diet modulates vascular response in A2AAR (+/+) and A 2AAR (-/-) mice: role of sEH, PPARγ, and K ATP channels.
Pradhan I; Ledent C; Mustafa SJ; Morisseau C; Nayeem MA
Mol Cell Biochem; 2015 Jun; 404(1-2):87-96. PubMed ID: 25739357
[TBL] [Abstract][Full Text] [Related]
15. Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.
Roche C; Guerrot D; Harouki N; Duflot T; Besnier M; Rémy-Jouet I; Renet S; Dumesnil A; Lejeune A; Morisseau C; Richard V; Bellien J
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():148-54. PubMed ID: 26022136
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
18. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.
Shen L; Peng H; Zhao S; Xu D
Biol Chem; 2014 Apr; 395(4):443-51. PubMed ID: 24225128
[TBL] [Abstract][Full Text] [Related]
19. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
